Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Does Merck Finally Have The Fodder It Needs To Buy Seagen?
05:09pm, Friday, 12'th Aug 2022
Seagen lost a royalty battle Friday, but SGEN stock jumped on the potential the rumored Merck acquisition could be looming. The post Does Merck Finally Have The Fodder It Needs To Buy Seagen?
J&J (JNJ) to Stop Selling Talc-based Baby Powder From 2023
03:21pm, Friday, 12'th Aug 2022 Zacks Investment Research
J&J (JNJ) will stop selling its talcum-based baby powder globally from next year. Though reports claim that the use of the talc causes cancer, JNJ maintains its stance that this product is safe.
STERIS (STE) Gains From Cantel Buyout, Supply Chain Issue Stays
02:05pm, Friday, 12'th Aug 2022 Zacks Investment Research
Revenue growth at STERIS' (STE) Applied Sterilization Technologies is driven by increased demand from medical device and biopharma customers.
How the Inflation Reduction Act will affect Medicare
01:45pm, Thursday, 11'th Aug 2022
Yahoo Finance's Anjalee Khemlani breaks down the impacts the Inflation Reduction Act could have on Medicare enrollees should Congress pass it.
10 defensive stocks that can also provide you with growth and dividends over the long term
10:05am, Wednesday, 10'th Aug 2022
The S&P 500 Index has rallied 10% since June 22 from a deep decline, but there are different schools of thought about whether investors are out of the woods yet.
Get ready for more merger mania in pharma sector the rest of the year
02:43pm, Tuesday, 09'th Aug 2022
Pfizer Inc.'s PFE, +0.24% $5.4 billion acquisition of Global Blood Therapeutics Inc. GBT, +0.02% is the latest sign that cash-flush drug makers are ready to jump back into dealmaking.
These 3 Dow Stocks Are Set to Soar in 2022's Second Half and Beyond
10:45am, Monday, 08'th Aug 2022
As the pandemic's impact continues to fade, several companies' situations are changing quickly.
5 High-Flying U.S. Corporate Giants to Buy Despite Volatility
09:47am, Monday, 08'th Aug 2022
We have narrowed our search to five U.S. corporate giants. These are; XOM, CVX, AEP, MRK and SO.
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
09:37am, Sunday, 07'th Aug 2022
Although they have moved in opposite directions this year, these two stocks should outperform for much of the next decade.
Should You Buy Merck Stock After An Upbeat Q2?
08:00am, Friday, 05'th Aug 2022
Merck stock (NYSE: MRK) reported its Q2 results last week, with revenue and earnings comfortably above ours and the street estimates.
Final Trades: Merck, Iron Mountain & more
02:54pm, Thursday, 04'th Aug 2022
The "Halftime Report" traders give their top picks to watch for the second half. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/2NGeIvi » Subscribe to CNBC TV:
3 Pharma Stocks' Post-Earnings Price Moves
06:06am, Thursday, 04'th Aug 2022
The health care sector is participating in the S&P's nascent rally, but pharmaceuticals AbbVie, Merck and Pfizer are holding up well relative to the market.
Merck KGaA's adjusted earnings boosted by strong dollar
01:03am, Thursday, 04'th Aug 2022
Germany's Merck KGaA saw adjusted earnings rise 13.1% in the second quarter as higher revenues from its biotech lab equipment and its chemicals for semiconductor production were further bolstered by a
Merck: Strong Oncology Pipeline
11:31am, Tuesday, 02'nd Aug 2022
Merck has an outstanding oncology portfolio that will drive growth in the foreseeable future. Strong fundamentals and cash position ensure Merck's growth will be well supported.
These eight health-care stocks can keep you invested in the market with less worry
10:52am, Tuesday, 02'nd Aug 2022
You're tempted to increase exposure to stocks because of the market's strength. But you're still gun shy because of the painful selloff.
